Not content with just providing the best possible care, our goal is to also find ways in delaying, or even preventing dementia. Anglicare’s Clinical Research Department was formed in 2012 with the launch of the KARVIAH clinical research study, the first of its kind to be conducted within a Retirement Village setting for people at an age most at risk. The study found that two important blood markers (fatty acids and ferritin) correlate with an elevated level of plaque in the brain, prior to the onset of dementia symptoms. These markers are not new. However, the correlation with the accumulating beta-amyloid protein, at a time when symptoms are not present, is highly significant.
Anglicare’s Clinical Research Department works collaboratively with the KaRa Institute of Neurological Diseases (KaRa MINDS) based in Macquarie Park, NSW, to advance research knowledge. KaRa MINDS not only conducts research into dementia but also provides education and training, advice and support for carers and those experiencing memory changes. For more information, see Anglicare’s Dementia Prevention Programs.
Anglicare’s aim is to provide the highest quality of care for people living with dementia while looking for ways to prevent the illness.
